Labcorp Operating Margin 2010-2024 | LH
Current and historical operating margin for Labcorp (LH) over the last 10 years. The current operating profit margin for Labcorp as of September 30, 2024 is 9.61%.
| Labcorp Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-09-30 |
$12.71B |
$0.75B |
5.88% |
| 2024-06-30 |
$12.49B |
$0.75B |
5.97% |
| 2024-03-31 |
$12.30B |
$0.72B |
5.82% |
| 2023-12-31 |
$12.16B |
$0.73B |
5.96% |
| 2023-09-30 |
$11.30B |
$0.79B |
7.02% |
| 2023-06-30 |
$11.11B |
$0.92B |
8.24% |
| 2023-03-31 |
$11.00B |
$1.08B |
9.81% |
| 2022-12-31 |
$11.87B |
$1.44B |
12.11% |
| 2022-09-30 |
$10.76B |
$2.01B |
18.69% |
| 2022-06-30 |
$11.96B |
$2.40B |
20.11% |
| 2022-03-31 |
$12.88B |
$2.68B |
20.81% |
| 2021-12-31 |
$13.14B |
$3.05B |
23.21% |
| 2021-09-30 |
$16.56B |
$3.82B |
23.09% |
| 2021-06-30 |
$16.39B |
$4.10B |
25.03% |
| 2021-03-31 |
$15.32B |
$3.70B |
24.13% |
| 2020-12-31 |
$13.98B |
$2.45B |
17.49% |
| 2020-09-30 |
$12.44B |
$1.49B |
11.96% |
| 2020-06-30 |
$11.48B |
$0.78B |
6.81% |
| 2020-03-31 |
$11.59B |
$0.82B |
7.07% |
| 2019-12-31 |
$11.56B |
$1.33B |
11.51% |
| 2019-09-30 |
$11.39B |
$1.30B |
11.43% |
| 2019-06-30 |
$11.29B |
$1.31B |
11.56% |
| 2019-03-31 |
$11.28B |
$1.34B |
11.87% |
| 2018-12-31 |
$11.33B |
$1.33B |
11.69% |
| 2018-09-30 |
$11.29B |
$1.35B |
11.94% |
| 2018-06-30 |
$11.08B |
$1.33B |
12.02% |
| 2018-03-31 |
$10.74B |
$1.29B |
12.04% |
| 2017-12-31 |
$10.31B |
$1.31B |
12.67% |
| 2017-09-30 |
$9.90B |
$1.26B |
12.69% |
| 2017-06-30 |
$9.70B |
$1.25B |
12.93% |
| 2017-03-31 |
$9.60B |
$1.29B |
13.44% |
| 2016-12-31 |
$9.55B |
$1.27B |
13.31% |
| 2016-09-30 |
$9.52B |
$1.22B |
12.85% |
| 2016-06-30 |
$9.42B |
$1.21B |
12.82% |
| 2016-03-31 |
$9.26B |
$1.16B |
12.58% |
| 2015-12-31 |
$8.68B |
$1.00B |
11.47% |
| 2015-09-30 |
$7.89B |
$0.98B |
12.37% |
| 2015-06-30 |
$7.13B |
$0.91B |
12.75% |
| 2015-03-31 |
$6.37B |
$0.83B |
13.07% |
| 2014-12-31 |
$6.01B |
$0.90B |
15.04% |
| 2014-09-30 |
$5.94B |
$0.91B |
15.26% |
| 2014-06-30 |
$5.85B |
$0.91B |
15.57% |
| 2014-03-31 |
$5.80B |
$0.93B |
16.07% |
| 2013-12-31 |
$5.81B |
$0.99B |
17.06% |
| 2013-09-30 |
$5.78B |
$0.99B |
17.16% |
| 2013-06-30 |
$5.73B |
$0.99B |
17.29% |
| 2013-03-31 |
$5.69B |
$1.00B |
17.55% |
| 2012-12-31 |
$5.67B |
$1.02B |
18.04% |
| 2012-09-30 |
$5.63B |
$1.06B |
18.75% |
| 2012-06-30 |
$5.62B |
$1.05B |
18.69% |
| 2012-03-31 |
$5.60B |
$1.00B |
17.87% |
| 2011-12-31 |
$5.54B |
$0.95B |
17.12% |
| 2011-09-30 |
$5.47B |
$0.94B |
17.18% |
| 2011-06-30 |
$5.34B |
$0.94B |
17.52% |
| 2011-03-31 |
$5.18B |
$0.98B |
18.95% |
| 2010-12-31 |
$5.00B |
$0.98B |
19.56% |
| 2010-09-30 |
$4.87B |
$0.96B |
19.61% |
| 2010-06-30 |
$4.78B |
$0.96B |
19.99% |
| 2010-03-31 |
$4.73B |
$0.93B |
19.65% |
| 2009-12-31 |
$4.70B |
$0.94B |
19.96% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$19.758B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
